Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Marks

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Seminars in Hematology|August 20, 2013
Hematologic manifestations of liver diseasePeter W Marks
Stem Cells and Development|January 18, 2020
Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on "Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction"Peter W Marks
Blood|August 4, 2012
Iron out for nontransfused thalassemiaPeter W Marks
Current Topics in Microbiology and Immunology|December 6, 2024
The Importance of Antibody Titer Determination to the Effective Use of Convalescent PlasmaPeter W Marks
Expert Review of Anticancer Therapy|February 29, 2012
Decitabine for acute myeloid leukemiaPeter W Marks
The New England Journal of Medicine|April 14, 2017
The Blood Supply and Men Who Have Sex with MenPeter W Marks
Annals of Internal Medicine|April 12, 2014
Update in hematology and oncology: evidence published in 2013Peter W Marks
Seminars in Perinatology|September 11, 2007
Management of thromboembolism in pregnancyPeter W Marks
Expert Review of Vaccines|February 21, 2023
COVID-19 vaccines: the start of a new era in regulation?Peter W Marks
Clinics in Chest Medicine|February 3, 2009
Coagulation disorders in the ICUPeter W Marks
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Seminars in Hematology|August 20, 2013
Hematologic manifestations of liver diseasePeter W Marks
Stem Cells and Development|January 18, 2020
Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on "Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction"Peter W Marks
Blood|August 4, 2012
Iron out for nontransfused thalassemiaPeter W Marks
Current Topics in Microbiology and Immunology|December 6, 2024
The Importance of Antibody Titer Determination to the Effective Use of Convalescent PlasmaPeter W Marks
Expert Review of Anticancer Therapy|February 29, 2012
Decitabine for acute myeloid leukemiaPeter W Marks
The New England Journal of Medicine|April 14, 2017
The Blood Supply and Men Who Have Sex with MenPeter W Marks
Annals of Internal Medicine|April 12, 2014
Update in hematology and oncology: evidence published in 2013Peter W Marks
Seminars in Perinatology|September 11, 2007
Management of thromboembolism in pregnancyPeter W Marks
Expert Review of Vaccines|February 21, 2023
COVID-19 vaccines: the start of a new era in regulation?Peter W Marks
Clinics in Chest Medicine|February 3, 2009
Coagulation disorders in the ICUPeter W Marks
Pageof 4